Vetter I - Search Results

1

Peigneur S, da Costa Oliveira C, de Sousa Fonseca FC, McMahon KL, Mueller A, Cheneval O, Cristina Nogueira Freitas A, Starobova H, Dimitri Gama Duarte I, Craik DJ, Vetter I, de Lima ME, Schroeder CI, Tytgat J. Peigneur S, et al. Among authors: vetter i. Biochem Pharmacol. 2021 Jan;183:114291. doi: 10.1016/j.bcp.2020.114291. Epub 2020 Oct 17. Biochem Pharmacol. 2021. PMID: 33075312 Free PMC article.

2

Characterization of endogenous calcium responses in neuronal cell lines.

Vetter I, Lewis RJ. Vetter I, et al. Biochem Pharmacol. 2010 Mar 15;79(6):908-20. doi: 10.1016/j.bcp.2009.10.020. Epub 2009 Oct 31. Biochem Pharmacol. 2010. PMID: 19883631

3

Chemical synthesis and structure of the prokineticin Bv8.

Morales RA, Daly NL, Vetter I, Mobli M, Napier IA, Craik DJ, Lewis RJ, Christie MJ, King GF, Alewood PF, Durek T. Morales RA, et al. Among authors: vetter i. Chembiochem. 2010 Sep 3;11(13):1882-8. doi: 10.1002/cbic.201000330. Chembiochem. 2010. PMID: 20677202

4

α-Conotoxin ImI incorporating stable cystathionine bridges maintains full potency and identical three-dimensional structure.

Dekan Z, Vetter I, Daly NL, Craik DJ, Lewis RJ, Alewood PF. Dekan Z, et al. Among authors: vetter i. J Am Chem Soc. 2011 Oct 12;133(40):15866-9. doi: 10.1021/ja206408q. Epub 2011 Sep 15. J Am Chem Soc. 2011. PMID: 21899353

5

Characterisation of Na(v) types endogenously expressed in human SH-SY5Y neuroblastoma cells.

Vetter I, Mozar CA, Durek T, Wingerd JS, Alewood PF, Christie MJ, Lewis RJ. Vetter I, et al. Biochem Pharmacol. 2012 Jun 1;83(11):1562-71. doi: 10.1016/j.bcp.2012.02.022. Epub 2012 Mar 3. Biochem Pharmacol. 2012. PMID: 22410003

6

Isolation, characterization and total regioselective synthesis of the novel μO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels.

Vetter I, Dekan Z, Knapp O, Adams DJ, Alewood PF, Lewis RJ. Vetter I, et al. Biochem Pharmacol. 2012 Aug 15;84(4):540-8. doi: 10.1016/j.bcp.2012.05.008. Epub 2012 May 16. Biochem Pharmacol. 2012. PMID: 22609441

7

Venom peptides as a rich source of cav2.2 channel blockers.

Sousa SR, Vetter I, Lewis RJ. Sousa SR, et al. Among authors: vetter i. Toxins (Basel). 2013 Feb 4;5(2):286-314. doi: 10.3390/toxins5020286. Toxins (Basel). 2013. PMID: 23381143 Free PMC article. Review.

8

Multiple actions of phi-LITX-Lw1a on ryanodine receptors reveal a functional link between scorpion DDH and ICK toxins.

Smith JJ, Vetter I, Lewis RJ, Peigneur S, Tytgat J, Lam A, Gallant EM, Beard NA, Alewood PF, Dulhunty AF. Smith JJ, et al. Among authors: vetter i. Proc Natl Acad Sci U S A. 2013 May 28;110(22):8906-11. doi: 10.1073/pnas.1214062110. Epub 2013 May 13. Proc Natl Acad Sci U S A. 2013. PMID: 23671114 Free PMC article.

9

Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors.

Inserra MC, Kompella SN, Vetter I, Brust A, Daly NL, Cuny H, Craik DJ, Alewood PF, Adams DJ, Lewis RJ. Inserra MC, et al. Among authors: vetter i. Biochem Pharmacol. 2013 Sep 15;86(6):791-9. doi: 10.1016/j.bcp.2013.07.016. Epub 2013 Aug 4. Biochem Pharmacol. 2013. PMID: 23924607

10

No gain, no pain: NaV1.7 as an analgesic target.

King GF, Vetter I. King GF, et al. Among authors: vetter i. ACS Chem Neurosci. 2014 Sep 17;5(9):749-51. doi: 10.1021/cn500171p. Epub 2014 Aug 11. ACS Chem Neurosci. 2014. PMID: 25111714 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page